Výsledky vyhledávání - "N B Mikhaylova"

Akademický článek

Rol' rituksimaba v lechenii nekhodzhkinskikh limfom(referativnyy obzor randomizirovannykh klinicheskikh issledovaniy)

Autor: N B Mikhaylova

Publikováno v: Современная онкология, Vol 11, Iss 3, Pp 28-31 (2009)

За последние 30 лет благодаря стремительному развитию молекулярной генетики и иммунологии радикальным образом изменилось представлени

Externí odkaz: https://doaj.org/article/ee273da70a3e456fa1c397075e8582ba

Zobrazit plný text záznamu

Akademický článek

Anti-monocyte globulin in allogeneic transplantation of hematopoietic stem cells

Autor: Yu. R. Zalyalov, B. A. Ganapiyev, V. G. Potapenko, N. B. Mikhaylova, B. V. Afanasyev

Publikováno v: Онкогематология, Vol 0, Iss 1-2, Pp 27-30 (2022)

Acute graft-versus-host disease (GFHD) and graft rejection reaction (GRR) early in the post-transplantation period are main complications of allogeneic transplantation of hematopoietic stem cells. We analyzed the incidence of principal early complica

Externí odkaz: https://doaj.org/article/1bc57579823243c19b6d1f186c68f95d

Zobrazit plný text záznamu

Akademický článek

Combined immunochemotherapy in patients with refractory/relapsed classical Hodgkin's lymphoma as a 2nd line treatment before autologous hematopoietic stem cell transplantation (preliminary results)

Publikováno v: Онкогематология, Vol 17, Iss 3, Pp 40-47 (2022)

Aim. To study the efficacy and safety of combined immunochemotherapy according to the DHAp protocol + nivolumab in patients with refractory/relapsed classical Hodgkin's lymphoma before autologous hematopoietic stem cell transplantation.Materials and

Externí odkaz: https://doaj.org/article/61dd8e7c89fc477eb1ba03f4c408b04b

Zobrazit plný text záznamu

The treatment of relapsed/refractory anaplastic large cell lymphoma expressing the anaplastic lymphoma kinase: a single-center experience

Autor: A. N. Galimov, E. E. Lepik, A. V. Kozlov, A. G. Gevorgian, I. V. Kazantsev, T. V. Yukhta, V. V. Baikov, A. N. Shvetsov, I. Yu. Nikolaev, P. S. Tolkunova, N. B. Mikhaylova, K. V. Lepik, Yu. А. Punanov, A. D. Kulagin, L. S. Zubarovskaya

Publikováno v: Pediatric Hematology/Oncology and Immunopathology. 22:22-31

Anaplastic large cell lymphoma (ALCL) expressing the anaplastic lymphoma kinase (ALK) (ALK+ ALCL) is a rare type of lymphoma which comprises 10-15% of all non-Hodgkin lymphomas in children and 2–3% in young adults. Relapsed/refractory disease occur

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::7dc7e8c179456d98c26b9cfac43fd349
https://doi.org/10.24287/1726-1708-2023-22-1-22-31

Zobrazit plný text záznamu

Akademický článek

PROGNOSTIC SIGNIFICANCE OF POSITRON EMISSION TOMOGRAPHY IN AUTOLOGOUS STEM CELL TRANSPLANTATION FOR NON-HODGKIN’S LYMPHOMA

Autor: V. G. Potapenko, N. B. Mikhaylova, B. I. Smirnov, I. A. Skorokhod, D. A. Chaginskaya, V. V. Ryabchikova, I. А. Samorodova, E. I. Podol’tseva, V. V. Ipatov, I. V. Boykov, V. N. Semelev, D. A. Gornostaev, T. G. Potapenko, T. G. Kulibaba, N. V. Medvedeva, B. V. Afanas’ev

Publikováno v: Онкогематология, Vol 11, Iss 4, Pp 18-24 (2017)

Objective: evaluation and comparison of positron emission tomography (PET) prognostic value with other predictors of effectiveness in patients with non-Hodgkin’s lymphoma (NHL) receiving high-dose chemotherapy with autologous hematopoietic stem cel

Externí odkaz: https://doaj.org/article/212c5c792aac40e695e2d4b29e9c47a2

Zobrazit plný text záznamu

Akademický článek

The optimal time for hematopoietic stem cell translantation for Hodgkin's lymphoma. International guidelines and real practic in Russia and former USSSR countries (Part II)

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, Ye. A. Demina, N. G. Tyurina, M. A. Vernyuk, Ye. Ye. Karamanesht, A. G. Rumyantsev

Publikováno v: Онкогематология, Vol 9, Iss 3, Pp 32-40 (2015)

The influence of previous antitumor therapy the efficacy and tolerability of high-dose chemotherapy with autologous hematopoietic progenitor cells transplantation (HCST) in 369 patients with Hodgkin, s lymphoma in the clinics of Russia and CIS countr

Externí odkaz: https://doaj.org/article/6198f3571091478eb4ccaf50b702f211

Zobrazit plný text záznamu

Akademický článek

The optimal time for autologous hematopoietic progenitor cell transplantation during treatment of Hodgkin's lymphoma. Foreign recommendations and russian experience

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasiev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, N. G. Tyurina, M. A. Vernyuk, E. E. Karamanesht, A. G. Rumyantsev

Publikováno v: Онкогематология, Vol 9, Iss 2, Pp 37-44 (2014)

Autologous hematopoietic stem cell transplantation (HSCT) is the standard treatment for patients with relapsed and primary refractoryHodgkin's lymphoma (HL). According to current recommendations HSCT must be performed in first relapse or after regist

Externí odkaz: https://doaj.org/article/a56bad078a754c72871958161f8aaadd

Zobrazit plný text záznamu

Akademický článek

Reduction in incidence of early fatal complications of high-dose chemotherapy with autologous hematopoietic stem cell transplantation in Hodgkin lymphoma patients

Autor: N. V. Zhukov, A. L. Uss, N. F. Milanovich, V. V. Ptushkin, B. V. Afanasyev, N. B. Mikhaylova, V. B. Larionova, E. A. Demina, E. E. Karamanesht, N. G. Tyurina, O. A. Pavlova, A. G. Rumyantsev, A. D. Kaprin

Publikováno v: Онкогематология, Vol 8, Iss 3, Pp 35-41 (2014)

Traditionally, the concern of fatal complication is a major obstacle to transfer patients with unfavorable course of Hodgkin’s lymphoma tonational transplantation centers. Early mortality after high-dose chemotherapy with autologous hematopoietic s

Externí odkaz: https://doaj.org/article/7a5306fe93d74836989d0867134fee12

Zobrazit plný text záznamu

Akademický článek

ROLE OF SERUM EOSINOPHILIC CATIONIC PROTEIN AND TRYPTASE IN MYELOPROLIFERATIVE AND LYMPHOPROLIFERATIVE DISORDERS

Autor: L. S. Komarova, N. B. Mikhaylova, I. I. Nesterovich, Ye. Ye. Zueva, B. V. Afanasyev, Areg A. Totolian

Publikováno v: Медицинская иммунология, Vol 10, Iss 4-5, Pp 361-370 (2014)

Abstract. A role of intracellular proteins of eosinophils and mast cells remains unclear in the patients with hematological neoplasia. There is a substantial evidence that eosinophils possess some common mechanisms of cooperation with mast cells. The

Externí odkaz: https://doaj.org/article/0fbf69df1261476a89eef9e17d24880b

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání